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Original Research Reports
Indicators of Cognitive Impairment
From a Medical Record Review:
Correlations With Early (30-d)
Readmissions Among Hospitalized
Patients in a Nephrology Unit
Matthew J. Jasinski, M.A., Mark A. Lumley, Ph.D., Sandeep Soman, M.D., Jerry Yee, M.D.,
Mark W. Ketterer, Ph.D.

Background: Patients with end-stage renal disease
have the highest 30-day hospital readmission rates of
any medical condition. Previous research suggests
that cognitive impairment contributes to readmission. It is important to identify patients at risk for early
readmission, and this might be accomplished efﬁciently
using medical record data. Method: We reviewed the
medical records of 100 patients with kidney disease (57
women, mean age ¼ 61.2) who were hospitalized in the
nephrology unit at an urban U.S. hospital. For each patient,
we recorded easily available indicators of cognitive
impairment along with other potential risk factors, and also
recorded the number of 30-day readmissions over the
past year. Results: Half of the sample (n ¼ 50) had at least
1 readmission (median ¼ 0.5, range: 0–20). A lifetime
history of delirium, which is a known marker of chronic

cognitive impairment, was signiﬁcantly related to readmissions, and several other impairment indicators (positive
head imaging, history of seizures, and history of hypoxia)
showed similar trends. A “cognitive impairment index”
(positive for one or more variables possibly reﬂecting
impaired central nervous system) was signiﬁcantly related
to the presence of a 30-day readmission, beyond the
effects of a number of behavioral and medical covariates.
Conclusions: Easily accessible cognitive impairment
markers, especially a known history of delirium, may be
useful to identify patients in nephrology units who are at
increased risk for early hospital readmissions. Interventions
can be targeted to these patients with the goal of reducing
the likelihood of readmissions and improving health care
outcomes.
(Psychosomatics 2017; 58:173–179)
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INTRODUCTION
Unplanned, early (i.e., 30-d) readmission rates vary
from hospital to hospital according to the Center for
Medicare and Medicaid Services (CMS). High readmission rates are attributed, in part, to suboptimal
discharge planning/preparation,1 and hospitals with
high readmission rates now face penalties of up to 3%
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of their reimbursement from the CMS under the
Affordable Care Act. Not only are these readmissions
potentially avoidable costs to the health care system,
but they also reﬂect ongoing or unresolved medical
issues for patients, which can result in death.2–8 Thus,
identifying and reducing potential causes of early
readmission may provide a cost-efﬁcient and effective
pathway to improve quality of care and avoid wasted
resources.9
Patients with chronic kidney disease (CKD), particularly the most serious form, end-stage renal disease
(ESRD), have the highest rates of early readmission (more
than 30% within 30 days) of any medical condition
nationwide.9 Patients with ESRD have extensive health
behavior requirements (e.g., dialysis, complex medication
regimens, ﬂuid and dietary restrictions), and studies
estimate that 30–60% of patients with ESRD are nonadherent to their treatment regimen.10 Ameliorating the
early readmission risk is especially urgent for populations
with pronounced health disparities due to racial and
socioeconomic factors.11,12
Psychiatric history, personality traits, health literacy, substance use, and a host of medical comorbidities have been implicated in negative outcomes for
patients with ESRD.13 Cognitive impairment may be
an important predictor of readmissions, but it is often
overlooked in medical settings.5,14–16 Previous
research has linked low scores on a brief cognitive
screen (the Mini-Cog) with a higher risk of early
readmissions in patients with ESRD.13
Studies of risk factors for negative health outcomes
have typically obtained such data from direct assessments
of patients through interviews, patient questionnaires, or
psychological testing. However, it would be ideal to
obtain such information in the least costly, most efﬁcient
manner possible. Thus, the objective of this retrospective
study was to identify correlates of early readmissions that
are easily identiﬁable from patient medical records.
Speciﬁcally, we hypothesized that correlates of cognitive
impairment from a medical record review would be
associated with early readmissions, even when controlling
for other previously established predictors.

tertiary hospital in relatively poor, largely ethnic minority,
urban area (Detroit, MI). The sample was 57% female,
85% African American, and had a mean age of 61.2 years
(standard deviation ¼ 14.7, range: 16–89). Common
comorbidities in this sample included diabetes (n ¼ 66),
smoking (n ¼ 66), and heart failure (n ¼ 36). See Table 1
for sample descriptive data.
Procedures
The study was approved by the siteʼs institutional
review board. The data were extracted from a retrospective medical record review of consecutive patients
who met study criteria. All variables extracted are ones
that are typically readily available from the historical
problem list of any standard medical record. In this
study, we used EPIC, which is the comprehensive
electronic medical record and information system at
this hospital.
Indicators of Cognitive Impairment

METHODS

A total of 6 variables that are probable indicators of
cognitive impairment and that are available in
patients' medical records were identiﬁed from the
literature and clinical experience. The following 6
variables were of lifetime history (rather than related
to the current hospitalization):
(1) Delirium: this variable captures any history of
acute cognitive impairment and was indicated by any
of several terms in the clinical history or problem/
diagnosis list: “delirium,” “encephalopathy,” or
“altered mental status.”17
(2) Positive results on head imaging scans: computed tomography or magnetic resonance imaging of
the head or brain with an interpretation of any of the
following descriptors: “periventricular white matter
ischemic changes,” “subdural hematoma,” “subarachnoid hemorrhage,” “normal pressure hydrocephalus,” “encephalomalacia,” “sclerotic (MS or ALS)
hyperintensitiy,” “generalized volume loss,” or “ageinappropriate atrophy.”
(3) Seizures, (4) hypoxia, (5) dementia, and (6)
stroke were also taken from the electronic medical
record master report list.

Participants

Comorbid Risk Factors

The sample was of 100 patients who were hospitalized on an inpatient nephrology unit in a major

Demographic risk factors included age, sex, and
race.
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TABLE 1.

Relationship of Demographic and Clinical Parameters to the Presence of an Early Readmission Within the Past Year
Total
N ¼ 100

Readmit
n ¼ 31

No readmit
n ¼ 89

t or χ

Demographics
Age (M, SD)
Sex (female)
Race—African American
Race—All other

61.2
57
85
15

(14.7)
(57%)
(85%)
(15%)

66.1
29
41
9

(13.8)
(29%)
(41%)
(9%)

53.6
28
44
6

(14.1)
(28%)
(44%)
(6%)

3.52**
0.04
0.76

Medical risk factors
ESRD
BUN (M, SD)
Creatinine (M, SD)
Diabetes
CHF
Smoking

65
38.0
5.71
66
36
66

(65%)
(21.2)
(4.34)
(66%)
(36%)
(66%)

40
41.2
6.04
36
25
32

(40%)
(18.7)
(3.40)
(36%)
(25%)
(32%)

25
34.9
5.39
30
11
34

(25%)
(23.3)
(5.13)
(30%)
(11%)
(34%)

9.89**
1.49
0.75
1.60
8.51**
0.18

Behavioral risk factors
Psychiatric diagnosis
Anxiety
Depression
Psychiatric medication
Substance abuse history
Alcohol abuse history
Substance use disorder
Positive tox screen

35
12
22
21
23
11
16
10

(35%)
(12%)
(22%)
(21%)
(23%)
(11%)
(16%)
(10%)

14
8
12
13
12
8
7
5

(14%)
(8%)
(12%)
(13%)
(12%)
(8%)
(7%)
(5%)

21
4
10
8
11
3
9
5

(21%)
(4%)
(10%)
(8%)
(11%)
(3%)
(9%)
(5%)

2.15
1.51
0.94
1.51
0.056
2.55
0.298
0.000

Cognitive indicators
Delirium
Positive head imaging
History of seizures
History of hypoxia
Dementia
Stroke history
Cognitive impairment index: 0 indicators
1 Indicator
2þ Indicators

21
14
8
13
6
9
57
30
13

(21%)
(14%)
(8%)
(13%)
(6%)
(9%)
(57%)
(30%)
(13%)

16
10
6
9
3
4
20
19
11

(16%)
(10%)
(6%)
(9%)
(3%)
(4%)
(20%)
(19%)
(11%)

5
4
2
4
3
5
37
11
2

(5%)
(4%)
(2%)
(4%)
(3%)
(5%)
(37%)
(11%)
(2%)

7.29**
2.99***
2.17
2.20
0.000
0.122
13.43**

Variable

BUN ¼ blood urea nitrogen; CHF ¼ congestive heart failure; ESRD ¼ end-stage renal disease; SD ¼ standard deviation, M ¼ mean.
nn

p o 0.01, 2-tailed.
p o 0.10.

nnn

A positive psychiatric history was indicated by the
presence of a psychiatric diagnosis or if the patient was
currently taking psychotropic medication. We also
analyzed these 2 variables individually.
History of substance use was indicated by either a
diagnosis of a substance use disorder or a positive
toxicology screen for illegal substances such as
cocaine, heroin, cannabis, and nonprescribed opioids.
History of alcohol abuse was also included as a
separate variable.
Comorbid medical risk factors included severity of
kidney disease (ESRD vs an earlier stage of CKD),
blood urea nitrogen and creatinine levels at the time of
Psychosomatics 58:2, March/April 2017

review, congestive heart failure (CHF), diabetes, and
smoking.
Outcome Variable: Early Readmissions
We examined the medical records for early readmissions over the 12 months before the current
admission for each patient. Early readmission was
coded for any patient who had 2 admissions (including “observation status”) within a 30-day period in
the past year. We analyzed this variable in 2 ways.
First, because our primary interest was in understanding which patients were likely to be readmitted
www.psychosomaticsjournal.org
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(and because the frequency of readmissions over the
past year was highly positively skewed), we dichotomously classiﬁed patients as to whether or not
they had at least 1 readmission. Second, the total
number of readmissions was analyzed as a continuous variable.
Data Analyses
We ran t-tests and chi-squares to examine relationships among clinical variables and the presence of an
early readmission within the past year, based on our a
priori hypotheses. Then, we entered signiﬁcant univariate correlates into a logistic regression with other
established medical predictors of readmissions to
compare their predictive validity. Finally, we also
developed a summary index of indicators of cognitive
impairment based on their ability to distinguish
patients who did or did not have an early readmission
within the past year. We compared readmissions
across the 3 levels of this index using both logistic
regression for dichotomous outcome (readmitted or
not) and using a nonparametric, median-based test for
ordinal predictors, the Jonckheere-Terpstra test.18 We
use a 2-tailed α of .05 to determine statistical
signiﬁcance.
RESULTS
The medical record review revealed that exactly half
the number of the patients (n ¼ 50) had an early
readmission during the past year, whereas other half
(n ¼ 50) did not. (In the full sample, the median number
of readmissions was 0.5; interquartile range: 0–1; M ¼
1.76; SD ¼ 3.76; range: 0–20.)
Table 1 displays correlates of readmission. Of the
demographic risk factors, older patients were moderately more likely to have an early readmission, but
race/ethnicity was unrelated. As expected, patients
with ESRD were more likely to have a past year early
readmission than those with earlier stages of CKD.
History of CHF was associated with early readmission, but diabetes, smoking, blood urea nitrogen, and
creatinine were not. Substance abuse and psychiatric
history were not related to early readmission. Note
that only 5 patients were diagnosed with a psychotic
disorder, and only 3 were taking antipsychotic medication at the time of review.
176
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Relationship of Cognitive Impairment Indicators to
Early Readmission
A history of delirium was the only individual
cognitive impairment indicator that was signiﬁcantly
related to the presence of an early readmission. It is
noteworthy that delirium remained signiﬁcantly associated with early readmission (odds ratio [OR] ¼ 3.69;
95% CI: 1.06–12.79; p ¼ 0.04) after controlling
simultaneously for age (OR ¼ 1.05; 95% CI: 1.02–
1.09; p ¼ 0.004), ESRD diagnosis (OR ¼ 4.79; 95% CI:
1.72–13.30 p ¼ 0.003), and CHF diagnosis (OR ¼
2.62; 95% CI: 0.97–7.09; p ¼ 0.013). The full model,
with all of these variables in it, was signiﬁcant (p o
0.001) and correctly classiﬁed 68% of early
readmissions.
The other 3 cognitive impairment indicators—
positive brain imaging, hypoxia, and seizures—were
2–3 times more common in patients who had a
readmission than those with no readmission, although
these indicators did not reach statistical signiﬁcance in
2-tailed tests. In contrast, dementia and stroke history
clearly were not associated with early readmission.
We used the 4 cognitive indicators that were at
least modestly associated with early readmissions
(delirium, positive head imaging, seizures, and hypoxia) and created a 3-level summary index in a manner
consistent with empirical criterion keying.19 The
incidence of each individual indicator was relatively
low, but together they represent risk factors for the
ﬁnal common pathogenic state of cognitive impairment. Patients were coded as having 0, 1, or 2þ of the
4 indicators. The 3 levels were strongly associated with
early readmissions, as displayed in Table 2. Patients
with either 1 indicator (OR ¼ 3.20; 95% CI: 1.27–8.02;
p ¼ 0.013) or 2þ indicators (OR ¼10.18; 95% CI:
2.05–50.59; p ¼ 0.005) had a substantially higher
likelihood of early readmission, compared to the
0 indicator group. After controlling for age, severity
of kidney disease (diagnosis of ESRD), and CHF
diagnosis, both 1 indicator and 2þ indicators

TABLE 2.

Comparison of the Number of Indicators of
Cognitive Impairment on Likelihood of
Readmission

0 Indicators
1 Indicator
2þ Indicators

Readmission

No readmission

20
19
11

37
11
2
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TABLE 3.

Final Full Model of Logistic Regression With Control Variables

Age
ESRD
CHF
1 Indicator
2þ Indicators

OR

95% CI

p Value

1.05
4.55
2.70
3.14
7.97

1.02–1.09
1.61–12.82
0.96–7.61
1.08–9.15
1.35–47.18

0.005
0.004
0.061
0.036
0.022

CHF ¼ congestive heart failure; OR ¼ odds ratio; ESRD ¼ end-stage renal disease.

remained signiﬁcant correlates of early readmission.
The full model, displayed in Table 3, was signiﬁcant
(p o 0.001) and correctly classiﬁed 74% of outcomes.
We also ran the above model, predicting the total
number of early readmissions during the year (rather
than simply the presence/absence of a readmission). In
this model, the cognitive impairment index was signiﬁcantly and strongly associated with the number
of early readmissions (TJT ¼ 1905.50, z ¼ 3.74, p o
0.001).
Finally, being positive on the cognitive impairment index remained signiﬁcantly associated with an
early readmission among the subset of the sample who
had no history of substance abuse (n ¼ 77).
DISCUSSION
This is the ﬁrst study to show an association between
cognitive impairment and early hospital readmissions
using only medical record information among patients
with CKD. In particular, patients with a history of
delirium were more than 3 times likely to have an early
hospital readmission during the past year than those
without a history of delirium. Moreover, early readmissions were 10 times more common when patients
had 2 or more indicators of cognitive impairment,
including not only a history of delirium but also a
history of positive head imaging, seizures, and hypoxia. Importantly, the relationship of cognitive impairment to early readmission remained signiﬁcant even
when controlling for the previously identiﬁed medical
risk factors of older age, severity of the kidney disease,
and history of CHF diagnosis.
The ﬁndings are consistent with the hypothesis
that indicators of cognitive impairment are important
correlates of early readmissions.13 A history of delirium and the other variables identiﬁed in this study
might be used to identify those patients with CKD who
Psychosomatics 58:2, March/April 2017

are most at risk for early readmissions. Such knowledge can direct limited resources to possible interventions for such cognitively impaired patients. For
example, teaching simpliﬁed behavioral prescriptions
to patients, assigning care managers to them, or
involving their families might increase patient adherence and reduce early readmissions. We advise providers to review patient records for these indicators of
cognitive impairment, given that they are so easily
accessible, and, at a minimum, devote extra care to
compensatory discharge planning to those patients
with elevated risk. We also suggest that cognitive
screenings be routinely and formally conducted on
patients admitted to hospitals, particularly because
hypoactive delirium is frequently overlooked.14
Although a full psychiatric evaluation would be ideal,
the current results demonstrate that a simple medical
record review can be used as a blunt instrument for
identifying at-risk patients.
This study also replicated previous research showing that older patients, patients with CHF, and
patients with more advanced stages of kidney disease
are more likely to have early readmissions.20 Importantly, however, the results also extend the literature
on early readmissions because previously identiﬁed
predictors have usually focused on medical comorbidities, whereas these cognitive impairment variables
typically fall into the behavioral/psychiatric domain
and are sometimes not noted by the medical staff. We
suspect that poor treatment adherence to the complex
medication reﬁlls/ingestion as well as dialysis may be
the mechanism by which cognitive impairment results
in repeated hospital admissions. Therefore, these
cognitive risk factors might be amenable to psychosocial interventions before and after discharge, which
represents an untapped area to improve patient care.
Speciﬁcally, we hypothesize that educating patients'
family members and asking them to help with
www.psychosomaticsjournal.org
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treatment adherence post-discharge might help compensate for some of the problems caused by cognitive
impairment. In fact, our research group is currently
testing such an intervention.
We found that psychiatric history was not a
signiﬁcant correlate of early readmissions. Although
we are not ruling this out as an important risk factor, it
is important to note that patients with a psychiatric
history are more likely than those without psychiatric
problems to attract attention from behavioral health
professionals in medical settings,21 whereas patients
who are cognitively impaired but psychiatrically stable
may go unnoticed, even though their readmission risk
is greater.5,16,22,23 On a related note, we believe this
reason is similar to why dementia and stroke history
were not associated with readmissions in our sample.
We expect that these patients are easier to identify than
those with mild-to-moderate cognitive impairment,
and already receive necessary attention through supports or being placed in assisted living facilities.
This study has a number of limitations. First, the
retrospective, correlational design of this study prevents us from drawing causal conclusions about these
results or identifying mechanisms. For example, the
cognitive impairment indicators could also carry risks
for readmission through medical comorbidities. Second, there probably were patients in our sample who
were false negatives for cognitive impairment owing to
the lack of these problems being identiﬁed or noted in
the medical record. This may have reduced the power
of our analyses, but also reafﬁrms the need to

accurately assess and manage symptoms of cognitive
impairment with inpatients. Third, the medical record
did not reliably have information on other important
factors such as social support, adherence, housing,
dialysis attendance, and readmissions to hospitals
outside of the health system. Therefore, these results
should be interpreted more as pragmatic information
for frontline practitioners than as a comprehensive
model of delirium. Finally, we also did not control for
multiple comparisons, although the number of potential cognitive indicators was small and we had a priori
hypotheses.
Despite these limitations, the evidence is compelling enough to warrant further prospective tests of the
relationship between cognitive impairment and negative outcomes post‐discharge, such as early readmissions. More research is needed to test possible
mediators, such as medication or dialysis nonadherence, that might link cognitive impairment to readmission. Moreover, behavioral interventions for
improving health outcomes after discharge need to
be tested for patients with CKD, especially those with
ESRD or cognitive impairment. Reducing early and
frequent hospital admissions would improve patients'
long-term health while simultaneously decreasing
costs to hospitals and increasing the efﬁciency of
our nation's health care system.
Disclosure: The authors disclosed no proprietary or
commercial interest in any product mentioned or concept discussed in this article.
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